Table 2.
Objective outcomes of patients with and without antibiotic spacers.
| Overall N = 9 |
No Antibiotic Spacer N = 5 |
With Antibiotic Spacer N = 4 |
p-Value | |
|---|---|---|---|---|
| Conversion to THA | 4 (44%) | 1 (20%) | 3 (75%) | 0.206 |
| THA requiring revision | 3/4 (75%) | 1/4 (25%) | 2/4 (50%) | 1.000 |
| Able to ambulate at final follow-up | 7 (78%) | 3 (60%) | 4 (100%) | 0.444 |
| Active intravenous drug use at final follow-up | 3 (33%) | 2 (40%) | 1 (25%) | 1.000 |
| Resolution of infection following initial procedure and hospitalization | 3 (33%) | 0 (0%) | 3 (75%) | 0.048 |
| Completed antibiotic course as prescribed | 5 (56%) | 2 (40%) | 3 (75%) | 0.524 |
| Second admission for infection in ipsilateral hip | 6 (67%) | 5 (100%) | 1 (25%) | 0.048 |
| Complete resolution of hip infection at final follow-up | 6 (67%) | 3 (60%) | 3 (75%) | 1.000 |
Patients who died or were paraplegic were excluded from these analyses. Values are reported as N (Percent). p-values for categorical variables were determined by Fisher’s exact test. Bold-face indicates statistical significance.